The Dual Effect of the BMP9–ALK1 Pathway in Blood Vessels: An Opportunity for Cancer Therapy Improvement?
The improvement of cancer therapy efficacy, the extension of patient survival and the reduction of adverse side effects are major challenges in cancer research. Targeting blood vessels has been considered a promising strategy in cancer therapy. Since the tumor vasculature is disorganized, leaky and...
Enregistré dans:
Auteurs principaux: | Blanca Ayuso-Íñigo, Lucía Méndez-García, Miguel Pericacho, José M. Muñoz-Félix |
---|---|
Format: | article |
Langue: | EN |
Publié: |
MDPI AG
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/0043a30176fb45b1b342110cadd8cd4f |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Novel Pathways for Targeting Tumor Angiogenesis in Metastatic Breast Cancer
par: Jordan A. Harry, et autres
Publié: (2021) -
Hypersensitivity in ALK-positive lung cancers exposed to ALK inhibitors: a case of successful switch to an alternative ALK inhibitor and systematic review of the literature
par: Deng L, et autres
Publié: (2018) -
Manejo clínico y terapéutico de un tumor fibroso pleural con translocación de ALK
par: Patricia Cruz-Castellanos, et autres
Publié: (2021) -
ALK rearranged non–small cell lung carcinoma with EML4-NTRK3 fusion as a possible mechanism of resistance to third-generation ALK inhibitors
par: Elena Corral de la Fuente, et autres
Publié: (2021) -
Clinicopathological and prognostic implications of ALK rearrangement in patients with completely surgically resected lung adenocarcinoma
par: Huan Zhang, et autres
Publié: (2021)